HSK-47388

N/A

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameHSK-47388
Drug Alias NameHSK47388HSK-47388
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin 23 Receptor modulators
TargetsInterleukin 23 Receptor
Therapy Area/IndicationsPlaque psoriasisPsoriasisInflammatory Bowel Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesHaisco Pharmaceutical Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesHaisco-Usa Pharmaceuticals IncHaisco Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisPsoriasisInflammatory Bowel Diseases +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A